Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
Classical Hodgkin lymphoma is now recognised as a B-cell lymphoma. Improved therapy has increased cure rates dramatically; however, relapse and death still occurs in a minority of patients. Much has been learned about the biology of Hodgkin and Reed Sternberg cells and their interactions with the microenvironment, which has informed studies exploring biologic markers that may improve upon clinical prognostic models. This manuscript reviews recent advances in our understanding of the pathobiology of cHL with an emphasis on biologic prognostic markers.
Hsi
Eric D
ED
Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA. hsie@ccf.org
D014408:Biomarkers, Tumor / Q000032:analysis; D006689:Hodgkin Disease / Q000175:diagnosis / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007249:Inflammation; D011379:Prognosis; D016539:Reed-Sternberg Cells / Q000473:pathology
D014408:Biomarkers, Tumor